🔬Cell & Gene Therapy
Living cell-based treatments including CAR-T, stem cells, and engineered immune cells for cancer and genetic diseases.
Market Cap$1.2T
1D-0.50%
Companies772
Public Cos98
SECTOR MARKET CAP
$1.2T+3823.3%ALL
TOP COMPANIES
| # | Company | Country | Valuation | Ticker |
|---|---|---|---|---|
| 1 |  | United States | $551.8B | JNJ |
| 2 |  | Switzerland | $281.1B | NVS |
| 3 |  | United States | $110.7B | BMY |
| 4 |  | United Kingdom | $101.7B | GSK |
| 5 |  | Switzerland | $43.3B | LONN.SW |
| 6 |  | Japan | $24.1B | 4503.T |
| 7 |  | China | $15.5B | WXXWY |
| 8 |  | United States | $10.8B | BMRN |
| 9 |  | United States | $10.4B | KRYS |
| 10 |  | United States | $7.6B | IBRX |
| 11 |  | United States | $5.6B | 950160.KQ |
| 12 |  | Netherlands | $2.9B | QURE |
| 13 |  | United States | $2.1B | VCEL |
| 14 |  | United States | $1.9B | TSHA |
| 15 |  | United States | $1.9B | SRPT |
| 16 |  | United States | $1.9B | IOVA |
| 17 |  | United States | $1.8B | PGEN |
| 18 |  | United States | $1.7B | CAPR |
| 19 |  | Germany | $1.4B | IMTX |
| 20 |  | United States | $1.3B | BLFS |